Immune effector cell-associated hemophagocytic lymphohistiocytosis-like syndrome (IEC-HS) Review


Authors: Lee, J. C.; Johnson, W. T.; Hines, M.; Shah, N. N.
Review Title: Immune effector cell-associated hemophagocytic lymphohistiocytosis-like syndrome (IEC-HS)
Keywords: review; disease classification; nonhuman; pathophysiology; comparative study; lymphocyte proliferation; t lymphocyte; infection; multiple myeloma; etoposide; incidence; cyclophosphamide; dexamethasone; histology; intensive care unit; b cell lymphoma; cytokine; disease severity; outcomes research; adoptive cell therapy; cell therapy; effector cell; methylprednisolone; corticosteroid; blood clotting disorder; cytopenia; adoptive immunotherapy; cell expansion; ferritin; thymocyte antibody; hemophagocytic syndrome; macrophage activation; cytokine release syndrome; hemophagocytic lymphohistiocytosis; basiliximab; disease grading; ruxolitinib; human; b cell acute lymphoblastic leukemia; chimeric antigen receptor t-cell immunotherapy; chimeric antigen receptor t-cell therapy; immune effector cell; anakinra; supportive care need; emapalumab; immune effector cell associated hemophagocytic lymphohistiocytosis like syndrome
Journal Title: Hematology/Oncology Clinics of North America
Volume: 39
Issue: 3
ISSN: 0889-8588
Publisher: Elsevier Inc.  
Date Published: 2025-06-01
Start Page: 617
End Page: 643
Language: English
DOI: 10.1016/j.hoc.2025.02.005
PUBMED: 40158936
PROVIDER: scopus
DOI/URL:
Notes: Review -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. William Thomas Johnson
    45 Johnson